Calibrate secures $100M in series B funding to revolutionize weight treatment.

Rob MacNaughhton, CEO at CalibrateWhat You Should Know:– Calibrate, the leading clinician-guided and value-based obesity treatment program, today announced the appointment of Rob MacNaughton as its new Chief Executive Officer.– Calibrate’s strategic direction under MacNaughton’s leadership and the OptumRx partnership position the company for significant growth and a positive impact on both individual and corporate healthcare landscapes.MacNaughton Bio/BackgroundMacNaughton boasts a distinguished track record in launching new healthcare ventures, overseeing product development, and scaling operations. Prior to Calibrate, MacNaughton served as Venture Chair at Redesign Health, overseeing the launch and growth of several healthcare delivery and technology brands. His previous roles include CEO positions at Curve Health and Nurse Grid, and Chief Product Officer at Cambia Health Solutions, a multi-state Blue Cross Blue Shield payor.“Obesity is the largest category of chronic disease and one of the biggest drivers of healthcare spending. I’m honored to join a company at the forefront of value-based obesity care and a business that is clearly committed to addressing the epidemic head on while helping employers and insurers manage soaring costs,” said Calibrate CEO, Rob MacNaughton. “Our commercial momentum is stronger than ever, and we are confident we will continue to collaborate with industry leaders to deliver best-in-class sustained outcomes.”